标题
Ebola virus disease candidate vaccines under evaluation in clinical trials
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 15, Issue 9, Pages 1101-1112
出版商
Informa UK Limited
发表日期
2016-05-10
DOI
10.1080/14760584.2016.1187566
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
- (2016) Stephen B Kennedy et al. Clinical Trials
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Duration of immune responses after Ebola virus vaccination
- (2016) Steven B Bradfute LANCET INFECTIOUS DISEASES
- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity
- (2016) Karen A.O. Martins et al. EBioMedicine
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
- (2015) Michelle Meyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Ebola vaccine R&D: Filling the knowledge gaps
- (2015) Donata Medaglini et al. Science Translational Medicine
- Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
- (2015) S. Herath et al. VACCINE
- Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein
- (2015) Karen Martins et al. VIRAL IMMUNOLOGY
- Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device
- (2015) Dinah H. Amante et al. Human Gene Therapy Methods
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses
- (2014) M. Wolferstatter et al. JOURNAL OF VIROLOGY
- A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
- (2014) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
- (2014) Karen A. O. Martins et al. PLoS One
- A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody
- (2014) Yu Wang et al. VIRUS RESEARCH
- The influence of delivery vectors on HIV vaccine efficacy
- (2014) Beatrice O. Ondondo Frontiers in Microbiology
- Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
- (2013) J. S. Richardson et al. JOURNAL OF VIROLOGY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant MVA vaccines: dispelling the myths
- (2013) Matthew G. Cottingham et al. VACCINE
- Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
- (2013) Wendy Peters et al. VACCINE
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- Prospects for oral replicating adenovirus-vectored vaccines
- (2013) Cailin Deal et al. VACCINE
- Characterization of a putative filovirus vaccine: Virus-like particles
- (2013) Karen A. O. Martins et al. VIROLOGICA SINICA
- An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models
- (2012) Ciaran D. Scallan et al. Clinical and Vaccine Immunology
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
- (2012) Roland Zahn et al. PLoS One
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Immune responses and protection in children in developing countries induced by oral vaccines
- (2012) Firdausi Qadri et al. VACCINE
- An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures
- (2012) Nicole Kilgore et al. Viruses-Basel
- Viral vectors as vaccine platforms: deployment in sight
- (2011) Christine S Rollier et al. CURRENT OPINION IN IMMUNOLOGY
- ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation
- (2011) Karin Lövgren Bengtsson et al. Expert Review of Vaccines
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
- (2010) Myron M Levine BMC BIOLOGY
- The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
- (2010) K. Radosevic et al. Clinical and Vaccine Immunology
- Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
- (2010) W. D. Pratt et al. Clinical and Vaccine Immunology
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
- (2010) T. K. Berthoud et al. CLINICAL INFECTIOUS DISEASES
- Adenovirus-Based Vaccines: Comparison of Vectors from Three Species ofAdenoviridae
- (2010) H. Chen et al. JOURNAL OF VIROLOGY
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?
- (2009) Manish Patel et al. JOURNAL OF INFECTIOUS DISEASES
- New Insights on Adenovirus as Vaccine Vectors
- (2009) Marcio O Lasaro et al. MOLECULAR THERAPY
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
- (2009) Ariane Rodríguez et al. VACCINE
- International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
- (2009) T. Christopher Mast et al. VACCINE
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
- (2008) Dana L Swenson et al. Expert Review of Vaccines
- Oral adenoviral-based vaccines: historical perspective and future opportunity
- (2008) Sean N Tucker et al. Expert Review of Vaccines
- Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of a Plasmodium falciparum Protein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1
- (2008) A. Rodriguez et al. INFECTION AND IMMUNITY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
- (2008) Maria A. Croyle et al. PLoS One
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals
- (2008) Lijuan Yang et al. VIROLOGY
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
- (2008) Alexander Bukreyev et al. VIROLOGY
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search